Literature DB >> 3287959

T-cell-rich B-cell lymphoma.

A D Ramsay1, W J Smith, P G Isaacson.   

Abstract

Five cases of B-cell lymphoma are described in which the morphology and initial immunohistochemistry suggested a diagnosis of T-cell neoplasia. In four cases, the histological picture was that of an adult pleomorphic T-cell lymphoma; the fifth case was a lymphocytic lymphoma (CLL) with an accompanying T-cell lymphocytosis in the peripheral blood. Immunohistochemistry on both frozen and paraffin-embedded material showed that the cellular population in all five cases consisted mainly of T-cells; less than 10% of the cells stained as B-cells. However, immunoglobulin immunostaining combined with use of the new lineage-related monoclonal antibodies reactive in paraffin section revealed that the B-cells constituted the neoplastic population. Genetic analysis showed no evidence of clonality in the T-cells, nor was it able to detect rearrangement in the small number of clonal B-cells present. These cases represent a variety of B-cell neoplasia that mimicks T-cell lymphoma morphologically and immunologically. The vigorous T-cell reaction seen in such lymphomas means that the malignant population can be correctly identified only by careful examination of the immunohistochemical findings.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3287959     DOI: 10.1097/00000478-198806000-00003

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  24 in total

1.  T-cell/histiocyte-rich large B-cell lymphoma.

Authors:  Stefania Pittaluga; Elaine S Jaffe
Journal:  Haematologica       Date:  2010-03       Impact factor: 9.941

2.  Morphological variability of tumour cells in T-cell-rich B-cell lymphoma. A histopathological study of 14 cases.

Authors:  S Camilleri-Bröet; T Molina; J Audouin; A L Tourneau; J Diebold
Journal:  Virchows Arch       Date:  1996-11       Impact factor: 4.064

3.  Non-Hodgkin's lymphoma involving the brain. Diagnostic usefulness of stereotactic needle biopsy in combination with paraffin-section immunohistochemistry.

Authors:  H Nakamine; H Yokote; T Itakura; S Hayashi; N Komai; Y Takano; K Saito; H Moriwaki; E Nishino; T Takenaka
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

4.  Immunophenotypic and genotypic characterization of diffuse mixed non-Hodgkin's lymphomas.

Authors:  W E Katzin; M D Linden; A J Fishleder; R R Tubbs
Journal:  Am J Pathol       Date:  1989-10       Impact factor: 4.307

5.  Monoclonal antibodies PG-B6a and PG-B6p recognize, respectively, a highly conserved and a formol-resistant epitope on the human BCL-6 protein amino-terminal region.

Authors:  L Flenghi; B Bigerna; M Fizzotti; S Venturi; L Pasqualucci; S Pileri; B H Ye; M Gambacorta; R Pacini; C D Baroni; E Pescarmona; I Anagnostopoulos; H Stein; G Asdrubali; M F Martelli; P G Pelicci; R Dalla-Favera; B Falini
Journal:  Am J Pathol       Date:  1996-05       Impact factor: 4.307

6.  Immunohistochemical analysis of Hodgkin's disease using microwave heating.

Authors:  C Charalambous; N Singh; P G Isaacson
Journal:  J Clin Pathol       Date:  1993-12       Impact factor: 3.411

7.  Primary T-cell rich B-cell lymphoma of the common bile duct.

Authors:  J P Brouland; J Molimard; J Nemeth; P Valleur; A Galian
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

8.  Diagnostic impact of molecular lineage analysis on paraffin-embedded tissue in hematolymphoid neoplasia reclassified by current WHO criteria.

Authors:  Leonard Hwan Cheong Tan; Lily-Lily Chiu; Evelyn Siew Chuan Koay
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

9.  T-cell-rich large-B-cell lymphomas contain non-activated CD8+ cytolytic T cells, show increased tumor cell apoptosis, and have lower Bcl-2 expression than diffuse large-B-cell lymphomas.

Authors:  R E Felgar; K R Steward; J B Cousar; W R Macon
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

Review 10.  Primary central nervous system lymphomas--an update.

Authors:  K A Jellinger; W Paulus
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.